Eli Lilly & Co. (LLY): If You're Going to Fail, Fail Quickly
It's not particularly surprising given that the drug failed a phase 3 trial in December, but it's still disappointing for a company that could really use a positive result.
Eli Lilly & Co (LLY)
Market is closed
News
- First
- << Previous
- 681 - 685
The Investor's Guide to Zoetis Inc (ZTS): Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)
Looking for the hottest name in health care? Right now it's not big pharma nor even a hot biotech firm making waves on Wall Street; it's newly minted animal health firm Zoetis Inc (NYSE:ZTS).
The Expense Of Diabetes: Is It Worth It? Eli Lilly & Co. (LLY), Novo Nordisk A/S (NVO), Abbott Laboratories (ABT)
With studies showing 33% of Americans with diabetes or pre-diabetes, it is obvious that the industry should be booming. Like most fields there is stiff competition in the industry.
5 Big Winners and Losers From Earnings Season: Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
Earnings season is a wrap for many of the brightest stars of the health care sector: Big pharma's big disappointments and successes are in the books, and investors are looking ahead to the future.
Newest Plays for Billion-Dollar Bridger Management
Most hedge fund managers can only dream of breaking the “billion-dollar ceiling” of the big leagues, and they remain content with a critical mass of nine-figures or less.
- First
- << Previous
- 681 - 685
Billionaire Hedge Funds
